Abbvie Inc

ABBV

$131.98

+23.6% last 12 months

Warren Buffett Holding value: $1.9 Billion Jim Simons Holding value: $273 Million Ken Griffin Holding value: $149 Million Joel Greenblatt Holding value: $13.9 Million Ray Dalio Holding value: $9.91 Million Ken Fisher Holding value: $4.66 Million Mario Gabelli Holding value: $3.27 Million Tom Russo Holding value: $1.7 Million Jeremy Grantham Holding value: $0 Cathie Wood Holding value: $0 Daniel Loeb Holding value: $0 Stanley Druckenmiller Holding value: $0 George Soros Holding value: $0 Donald Yacktman Holding value: $0

Market Cap

$235 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

52 Week Range

$97.28 - $137.98

The lowest and highst price in the last 52 weeks.

Price-Earnings Ratio

31.51x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

Dividends per Share

$5.23 (3.93%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Revenue & Earnings

Balance Sheet

Share Statistics

Market Cap $235 Billion
Enterprise Value $304 Billion
Dividend Yield $5.23 (3.93%)
1 Year Return +27.6%
52-Week High $137.98
52-Week Low $97.28
Beta 0.57
Outstanding Shares 1.77 Billion
Avg 30 Day Volume 6.95 Million

Valuation

P/E Ratio 31.51
PEG 83.26
Earnings per Share $4.19
Price to Sales Ratio 4.26
Price to Book Ratio 18.85
Revenue to Enterprise Value 5.5
EBIT to Enterprise Value 16.97
Total Debt to Enterprise Value 0.27
Debt to Equity 5.96

Profitability

Revenue $55.2 Billion
Gross Profit $37.4 Billion
EBIT $17.9 Billion
Net Income $7.46 Billion
Profit Margin 13.52%
Quarterly Earnings Growth (YoY) +37.8%
Return on Equity 55.06%
Return on Assets 5.01%
Return on Invested Capital 14.87%

Insider trades

No purchases

4,184 shares sold (1 transactions)

No purchases

5,057 shares sold (1 transactions)

No purchases

114,857 shares sold (5 transactions)

No purchases

No sells

Q2 2021 Q3 2021 Q4 2021 Q1 2022

About Abbvie Inc

CEO: Richard Gonzalez

Industry: Pharmaceutical Preparation Manufacturing

Similar stocks

Pfizer Inc.
Pfizer Inc.
Lilly(Eli) & Co
Lilly(Eli) & Co
AMGEN Inc.
AMGEN Inc.
Gilead Sciences, Inc.
Gilead Sciences, Inc.
Biogen Inc
Biogen Inc
Glaxosmithkline plc - ADR
Glaxosmithkline plc - ADR
Astrazeneca plc - ADR
Astrazeneca plc - ADR
Neurocrine Biosciences, Inc.
Neurocrine Biosciences, Inc.

News

Wendell David Associates Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Wendell David Associates Inc. Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)

Wendell David Associates Inc. lifted its holdings in shares of AbbVie Inc. (NYSE:ABBV) by 1.6% in the 3rd quarter, according to its most recent Form 13F fili...

Transcript Daily Transcript Daily, about 2 months ago
Bangor Savings Bank Buys 3,437 Shares of AbbVie Inc. (NYSE:ABBV)

Bangor Savings Bank Buys 3,437 Shares of AbbVie Inc. (NYSE:ABBV)

Bangor Savings Bank boosted its stake in shares of AbbVie Inc. (NYSE:ABBV) by 29.1% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 15,240 sh...

Dakota Financial News Dakota Financial News, about 2 months ago
Pancreatitis Drugs Market to Witness Growth Acceleration | GSK, AbbVie Inc, Medinova

Pancreatitis Drugs Market to Witness Growth Acceleration | GSK, AbbVie Inc, Medinova

Pancreatitis Drugs Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The report answe...

OpenPR OpenPR, about 2 months ago
Heres What to Focus on: Bilibili Inc. (NASDAQ:BILI), AbbVie Inc. (NYSE:ABBV)

Heres What to Focus on: Bilibili Inc. (NASDAQ:BILI), AbbVie Inc. (NYSE:ABBV)

Bilibili Inc. (BILI) with the stream of 4.85% also noticed, India AbbVie Inc. (ABBV) encountered a rapid change of -0.03% in the last hour of Wednesdays trad...

Stock Equity Stock Equity, about 2 months ago
Never miss a trade
To improve your user experience we use cookies.